Showing results (441-450 of 557) with videos related to

Sort By:
Pageof 56
Journal of Neurology|June 14, 2019
End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life PlanningNoelle E Carlozzi, Nicholas R Boileau, Jane S Paulsen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2020
Resting-State Functional Connectivity Predicts STN DBS Clinical ResponseJohn R Younce, Meghan C Campbell, Tamara Hershey, et al.
Cells|August 13, 2025
Pilot Study of [11C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET RadiotracerChia-Ju Hsieh, Dinahlee Saturnino Guarino, Anthony J Young, et al.
Neurology|April 14, 2022
Proteinopathy and Longitudinal Cognitive Decline in Parkinson DiseasePeter S Myers, John L O'Donnell, Joshua J Jackson, et al.
Brain : a Journal of Neurology|August 14, 2008
Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson diseaseM Karimi, N Golchin, S D Tabbal, et al.
Annals of Neurology|July 22, 2014
Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primatesLaura L Dugan, LinLin Tian, Kevin L Quick, et al.
Synapse (New York, N.Y.)|April 27, 2012
Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PETSarah A Eisenstein, Jon M Koller, Marilyn Piccirillo, et al.
Bioorganic & Medicinal Chemistry|May 8, 2025
Synthesis and in vivo biological characterization of six carbon-11 sigma-1 receptor radiotracers in rodent and nonhuman primateAnil Kumar Soda, Tianyu Huang, Wenjuan Zhou, et al.
Frontiers in Neurology|May 19, 2017
Research Priorities in Limb and Task-Specific DystoniasSarah Pirio Richardson, Eckart Altenmüller, Katharine Alter, et al.
ACS Chemical Neuroscience|September 13, 2021
InVitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H]CS1P1 and [11C]CS1P1Hao Jiang, Sumit Joshi, Hui Liu, et al.
Pageof 56